{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:07:30Z","timestamp":1792868850324,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.vaccine.2015.01.065","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T13:32:00Z","timestamp":1423315920000},"page":"1446-1452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: Data from the international COMORA cohort"],"prefix":"10.1016","volume":"33","author":[{"given":"Ihsane","family":"Hmamouchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Winthrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.01.065_bib0215","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0220","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.vaccine.2015.01.065_bib0225","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.berh.2007.05.003","article-title":"Mortality in established rheumatoid arthritis","volume":"21","author":"Naz","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0230","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0235","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.10529","article-title":"Predictors of infection in rheumatoid arthritis","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0240","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semarthrit.2008.10.002","article-title":"The risk of infections with biologic therapies for rheumatoid arthritis","volume":"39","author":"Furst","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0245","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0889-857X(05)70087-9","article-title":"Vaccination of the immunosuppressed adult patient with rheumatologic disease","volume":"25","author":"Avery","year":"1999","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0250","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.vaccine.2015.01.065_bib0255","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2012-202658","article-title":"Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy","volume":"72","author":"Mori","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"Dec","key":"10.1016\/j.vaccine.2015.01.065_bib0260","article-title":"Effect of methotrexate, anti-TNF\u03b1 and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis","author":"Hua","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/rheumatology\/kei237","article-title":"Vaccinate your immunocompromised patients","volume":"45","author":"Gluck","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0270","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1183\/09059180.00008911","article-title":"The remaining challenges of pneumococcal disease in adults","volume":"21","author":"Ludwig","year":"2012","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0275","first-page":"1","article-title":"Prevention of pneumococcal disease: recommendations of the advisory committee on immunization practices (ACIP)","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0280","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 Update of the 2008 American College of Rheumatology Recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0285","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.065_bib0290","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.reuma.2011.01.005","article-title":"Vaccines and chemo-prophylaxis in rhemautoid arthritis: is a vaccine calendar necessary?","volume":"7","author":"Garrido L\u00f3pez","year":"2011","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0295","series-title":"Summary of product characteristics","article-title":"Prevenar 13","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0300","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/rheumatology\/keq297","article-title":"Routinely measuring and reporting pneumococcal vaccination among immunosuppressed rheumatology outpatients: the first step in improving quality","volume":"50","author":"Desai","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0305","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/ard.2007.081703","article-title":"Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease","volume":"67","author":"Lanternier","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0310","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/rheumatology\/keq183","article-title":"Vaccinations in patients with immune-mediated inflammatory diseases","volume":"49","author":"Rahier","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0315","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","article-title":"Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)","volume":"73","author":"Dougados","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0320","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0325","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.065_bib0330","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.reuma.2011.01.005","article-title":"Vaccines and chemo-prophylaxis in rhemautoid arthritis: is a vaccine calendar necessary?","volume":"7","author":"Garrido L\u00f3pez","year":"2001","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0335","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/ard.2006.060285","article-title":"Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis","volume":"66","author":"Pradeep","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2015.01.065_bib0340","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.healthpol.2012.05.012","article-title":"The vaccine gap between Japan and the UK","volume":"107","author":"Shimazawa","year":"2012","journal-title":"Health Policy Vaccines"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0345","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1016\/j.vaccine.2011.10.030","article-title":"Seasonal influenza vaccine provision in 157 countries (2004\u20132009) and the potential influence of national public health policies","volume":"29","author":"Palache","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0350","series-title":"Strengthening vaccination policies in Latin America","author":"Commission on the Future of Vaccines in Latin America","year":"2008"},{"issue":"37","key":"10.1016\/j.vaccine.2015.01.065_bib0355","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1016\/j.vaccine.2012.12.062","article-title":"Strengthening vaccination policies in Latin America: an evidence-based approach","volume":"31","author":"Tapia-Conyer","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0360","first-page":"1102","article-title":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"40","key":"10.1016\/j.vaccine.2015.01.065_bib0365","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.065_bib0370","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00296-013-2907-9","article-title":"Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases","volume":"34","author":"Papadopoulou","year":"2014","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.065_bib0375","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jbspin.2013.09.001","article-title":"Club Rhumatismes et Inflammations (CRI). French Society for Rheumatology. Recommendations for using TNF\u03b1 antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health","volume":"80","author":"Go\u00ebb","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0380","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/j.ijid.2013.01.004","article-title":"Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention","volume":"17","author":"Hung","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"Apr (16)","key":"10.1016\/j.vaccine.2015.01.065_bib0385","first-page":"308","article-title":"Progress in introduction of pneumococcal conjugate vaccine\u2014worldwide, 2000\u20132012","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0390","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.1016\/j.ijid.2010.02.2262","article-title":"Clinical and economic burden of pneumonia among adults in Latin America","volume":"14","author":"Isturiz","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0395","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1016\/j.vaccine.2010.08.010","article-title":"Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan","volume":"28","author":"Kawakami","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0400","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10096-010-0873-7","article-title":"Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan","volume":"29","author":"Liao","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0405","doi-asserted-by":"crossref","first-page":"B81","DOI":"10.1016\/j.vaccine.2012.11.085","article-title":"Global support for new vaccine implementation in middle-income countries","volume":"31","author":"Kaddar","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0410","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/ard.62.7.685","article-title":"Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis","volume":"62","author":"Bridges","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.01.065_bib0415","unstructured":"United Kingdom Health Protection Agency. Vaccine uptake guidance and the latest coverage data \u3008http:\/\/www.hpa.org.uk\u3009."},{"issue":"8","key":"10.1016\/j.vaccine.2015.01.065_bib0420","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.vaccine.2013.12.020","article-title":"Pneumococcal vaccine targeting strategy for older adults: customized risk profiling","volume":"32","author":"Balicer","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T14:55:46Z","timestamp":1566312946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1500122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0264410X1500122X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: Data from the international COMORA cohort","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}